[Diagnosis and treatment of alcoholic liver disease with HCV].
Tsutsumi
Mikihiro
M
Division of Gastroenterology, Department of Internal Medicine, Kanazawa Medical University.
Takase
Shujiro
S
D000428:Alcohol Drinking / Q000009:adverse effects; D000998:Antiviral Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D006528:Carcinoma, Hepatocellular / Q000453:epidemiology / Q000209:etiology; D016174:Hepacivirus / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification*; D018937:Hepatitis C Antibodies / Q000097:blood; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D008108:Liver Diseases, Alcoholic / Q000150:complications / Q000175:diagnosis / Q000628:therapy / Q000821:virology*; D008113:Liver Neoplasms / Q000453:epidemiology / Q000209:etiology; D012367:RNA, Viral / Q000097:blood; D012306:Risk; D013695:Temperance
D000998:Antiviral Agents; D015415:Biomarkers; D018937:Hepatitis C Antibodies; D012367:RNA, Viral; D007372:Interferons